UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

UK guideline for the use of HIV post-exposure prophylaxis 2021

Cresswell, Fiona; Asanati, Kaveh; Bhagani, Sanjay; Boffito, Marta; Delpech, Valerie; Ellis, Jayne; Fox, Julie; ... Gupta, Nadi; + view all (2022) UK guideline for the use of HIV post-exposure prophylaxis 2021. HIV Medicine 10.1111/hiv.13208. Green open access

[thumbnail of Rodger_UK guideline for the use of HIV post-exposure prophylaxis 2021.pdf]
Preview
Text
Rodger_UK guideline for the use of HIV post-exposure prophylaxis 2021.pdf - Published Version

Download (697kB) | Preview

Abstract

We present the updated British Association for Sexual Health and HIV (BASHH) guidelines for post-exposure prophylaxis (PEP) to HIV following sexual exposures, occupational exposures and other nonoccupational exposures in the community. This serves as an update to the 2015 BASHH guideline on PEP following sexual exposures and the 2008 Expert Advisory Group on AIDS guidelines on HIV PEP. We aim to provide evidence-based guidance on best clinical practice in the provision, monitoring and support of PEP for the prevention of HIV acquisition following sexual, occupational and other nonoccupational exposures in the community. The guideline covers when to prescribe PEP, what antiretroviral agents to use and how to manage PEP. This includes (i) evidence of PEP efficacy; (ii) evidence relating to individual-level efficacy of antiretroviral therapy to prevent the sexual transmission of HIV; (iii) data on the detectable (transmissible) prevalence of HIV in specific populations; (iv) risk of HIV transmission following different types of sexual and occupational exposure; (v) baseline risk assessment; (vi) drug regimens and dosing schedules; (vii) monitoring PEP; (viii) baseline and follow-up blood-borne virus testing; (ix) the role of PEP within broader HIV prevention strategies, for example, HIV pre-exposure prophylaxis (PrEP). The guideline also covers special scenarios such as PEP in pregnancy, breastfeeding and chronic hepatitis B virus infection, and when PEP should be considered in people using HIV PrEP. The guidelines are aimed at clinical professionals directly involved in PEP provision and other stakeholders in the field. A proforma to assist PEP consultations is included. A public consultation process was undertaken prior to finalizing the recommendations.

Type: Article
Title: UK guideline for the use of HIV post-exposure prophylaxis 2021
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/hiv.13208
Publisher version: https://doi.org/10.1111/hiv.13208
Language: English
Additional information: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
URI: https://discovery.ucl.ac.uk/id/eprint/10144109
Downloads since deposit
112Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item